StonvexLoading…
StonvexStonvexStonvexCore line items from DV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $180.82M | $748.29M | $542.70M | $354.08M |
Operating Income | $15.64M | $79.20M | $41.41M | $20.31M |
Net Income | $6.41M | $50.65M | $21.32M | $8.76M |
EPS (Diluted) | $0.04 | $0.30 | $0.13 | $0.07 |
Total Assets | $1.27B | $1.35B | $1.30B | $1.30B |
Total Liabilities | $193.14M | $222.75M | $219.65M | $206.91M |
Cash & Equivalents | $173.80M | $259.04M | $200.73M | $211.78M |
Free Cash Flow OCF − CapEx | $-6.37M | $172.65M | $110.50M | $71.46M |
Shares Outstanding | 155.93M | 161.90M | 161.09M | 163.57M |